[1]
Y. Nassar, “Tocilizumab Therapy in Critically Ill Patients with Coronavirus Disease-2019 Pneumonia – A Propensity Score-Adjusted Analysis”, Open Access Maced J Med Sci, vol. 11, no. B, pp. 480–488, Jan. 2023.